

关联产品推荐

EGFR Fc Chimera Protein, Rhesus macaque
规格:100μg
价格:¥2,800.00

EGFR His Tag Protein, Mouse
规格:25μg
价格:¥1,440.00
产品介绍 评论(0)
物种
Human分子别名
EFNA1,LERK-1,TNFAIP4,EPLG1,B61,ECKLG,EFL1Accession
P20827-1表达序列
Asp19-Ser182, with C-terminal 8*His表达宿主
HEK293分子量
23-30kDa (Reducing)纯度
>95% by SDS-PAGE
内毒素含量
<0.1EU/μg标记
Unconjugated标签
His Tag性状
Lyophilized Powder缓冲体系
PBS, pH7.4溶解方法
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.储存条件
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.
EPH-related receptor tyrosine kinase ligand 1 (abbreviated as Ephrin-A1) also known as ligand of eph-related kinase 1 or EFNA1, is a member of the ephrin (EPH) family. The Eph family receptor interacting proteins (ephrins) are a family of proteins that serve as the ligands of the Eph receptor, which compose the largest known subfamily of receptor protein-tyrosine kinases (RTKs). Ephrin-A1/EFNA1 and its Eph family of receptor tyrosine kinases are expressed by cells of the SVZ. Ephrin subclasses are further distinguished by their mode of attachment to the plasma membrane: ephrin-A ligands bind EphA receptors and are anchored to the plasma membrane via a glycosylphosphatidylinositol (GPI) linkage, whereas ephrin-B ligands bind EphB receptors and are anchored via a transmembrane domain. An exception is the EphA4 receptor, which binds both subclasses of ephrins. Ephrin-A1 and its receptor EphA2 were expressed in xenograft endothelial cells and also tumor cells and play a role in human cancers, at least in part by influencing tumor neovascularization.
电泳
- 2μg (R: reducing conditions, N: non-reducing conditions).
ELISA
Immobilized Ephrin-A1 His Tag, Human (Cat. No. UA010170) at 2.0μg/mL (100μL/well) can bind Biotinylated EphA2 His&Avi Tag (Cat. No. UA010833) with EC50 of 0.25-0.36μg/mL .







评论(0)